These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19952380)

  • 1. Foam sclerotherapy techniques: different gases and methods of preparation, catheter versus direct injection.
    Cavezzi A; Tessari L
    Phlebology; 2009 Dec; 24(6):247-51. PubMed ID: 19952380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerotherapy and foam sclerotherapy for varicose veins.
    Coleridge Smith P
    Phlebology; 2009 Dec; 24(6):260-9. PubMed ID: 19952382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified Tessari Tourbillon technique for making foam sclerotherapy with silicone-free syringes.
    Whiteley MS; Patel SB
    Phlebology; 2015 Oct; 30(9):614-7. PubMed ID: 25288590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation into the influence of various gases and concentrations of sclerosants on foam stability.
    Peterson JD; Goldman MP
    Dermatol Surg; 2011 Jan; 37(1):12-7. PubMed ID: 21199095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of published information on foam sclerotherapy.
    Stücker M; Kobus S; Altmeyer P; Reich-Schupke S
    Dermatol Surg; 2010 Jun; 36 Suppl 2():983-92. PubMed ID: 20590705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications and side-effects of foam sclerotherapy.
    Guex JJ
    Phlebology; 2009 Dec; 24(6):270-4. PubMed ID: 19952383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of published reports of foam sclerotherapy: what do we know conclusively?
    Myers KA; Roberts S
    Phlebology; 2009 Dec; 24(6):275-80. PubMed ID: 19952384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound-guided catheter-directed foam sclerotherapy for great saphenous vein.
    Kurdal AT; Yildirim F; Ozbakkaloglu A; Iskesen I; Tetik O
    Minerva Chir; 2015 Feb; 70(1):33-6. PubMed ID: 25650651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking the saphenofemoral junction during ultrasound-guided foam sclerotherapy-- assessment of a presumed safety-measure procedure.
    Ceulen RP; Jagtman EA; Sommer A; Teule GJ; Schurink GW; Kemerink GJ
    Eur J Vasc Endovasc Surg; 2010 Dec; 40(6):772-6. PubMed ID: 20926321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter Foam Sclerotherapy of the Great Saphenous Vein, with Perisaphenous Tumescence Infiltration and Saphenous Irrigation.
    Cavezzi A; Mosti G; Campana F; Tessari L; Bastiani L; Urso SU
    Eur J Vasc Endovasc Surg; 2017 Nov; 54(5):629-635. PubMed ID: 28927554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Air versus physiological gas for ultrasound guided foam sclerotherapy treatment of varicose veins.
    Beckitt T; Elstone A; Ashley S
    Eur J Vasc Endovasc Surg; 2011 Jul; 42(1):115-9. PubMed ID: 21531588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound-guided foam sclerotherapy: safety and efficacy.
    Morrison N
    Phlebology; 2009 Dec; 24(6):239. PubMed ID: 19952378
    [No Abstract]   [Full Text] [Related]  

  • 13. Commentary: An investigation into the influence of various gases and concentrations of sclerosants on foam stability.
    Frullini A
    Dermatol Surg; 2011 Jan; 37(1):17-8. PubMed ID: 21214662
    [No Abstract]   [Full Text] [Related]  

  • 14. Foam and liquid sclerotherapy for varicose veins.
    Coleridge Smith P
    Phlebology; 2009; 24 Suppl 1():62-72. PubMed ID: 19307442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foam sclerotherapy for the treatment of superficial venous insufficiency.
    Gibson KD; Ferris BL; Pepper D
    Surg Clin North Am; 2007 Oct; 87(5):1285-95, xii-xiii. PubMed ID: 17936487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saphenous ablation: sclerosant or sclerofoam?
    Coleridge Smith P
    Semin Vasc Surg; 2005 Mar; 18(1):19-24. PubMed ID: 15791549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should foam made with physiologic gases be the standard in sclerotherapy?
    Wong M
    Phlebology; 2015 Oct; 30(9):580-6. PubMed ID: 25392457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up. "The 3/1 Study".
    Hamel-Desnos C; Ouvry P; Benigni JP; Boitelle G; Schadeck M; Desnos P; Allaert FA
    Eur J Vasc Endovasc Surg; 2007 Dec; 34(6):723-9; discussion 730. PubMed ID: 17884623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological and chest symptoms following sclerotherapy: a single centre experience.
    Hill DA
    Phlebology; 2014 Oct; 29(9):619-27. PubMed ID: 23945346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A convenient source of carbon dioxide for sclerosant foams.
    Parsi K; Exner T; Connor DE; Joseph JE; Fung DD
    Dermatol Surg; 2006 Dec; 32(12):1533-4. PubMed ID: 17199670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.